diethylene glycol monoethyl ether
Small moleculeexperimental
Diethylene glycol monoethyl ether (under brand name Transcutol) is used as a vehicle in the formulation or manufacturing process of pharmaceuticals, cosmetics, and food additives. Transcutol is safe for use and has low irritancy inferred by numerous toxicological studies and precedence of use in approved topical medicines. — NCATS
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 31, 2026 (NCT07273916)
Timeline
2020s
- Jan 1, 2026
Earliest Phase 2 Sponsor(trial)
Mechanism of action
- Unspecified target
Excipient
Chemistry & pharmacology
Loading structure…
SMILES
CCOCCOCCO- Mol. weight
- 134.1736 g/mol
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSA1A1I8X02B ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07273916 | Phase 2 | Mar 31, 2026 | Hexsel Dermatology Clinic |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hexsel Dermatology Clinic | Academic/Hospital | 1 | 1 | 1 | 2026 |
1 organizations
Page 1 / 1